Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 7 |
NetGPI | no | yes: 0, no: 7 |
Related structures:
AlphaFold database: A4IDC0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 88 | 92 | PF00656 | 0.459 |
CLV_NRD_NRD_1 | 14 | 16 | PF00675 | 0.606 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.589 |
CLV_PCSK_KEX2_1 | 14 | 16 | PF00082 | 0.653 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.583 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.656 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.496 |
CLV_PCSK_PC1ET2_1 | 64 | 66 | PF00082 | 0.656 |
CLV_PCSK_PC1ET2_1 | 77 | 79 | PF00082 | 0.496 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.602 |
CLV_PCSK_SKI1_1 | 78 | 82 | PF00082 | 0.600 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.626 |
DOC_CKS1_1 | 72 | 77 | PF01111 | 0.641 |
DOC_MAPK_gen_1 | 14 | 24 | PF00069 | 0.631 |
DOC_MAPK_gen_1 | 148 | 157 | PF00069 | 0.420 |
DOC_MAPK_MEF2A_6 | 14 | 22 | PF00069 | 0.536 |
DOC_USP7_MATH_1 | 103 | 107 | PF00917 | 0.404 |
DOC_USP7_MATH_1 | 41 | 45 | PF00917 | 0.684 |
DOC_WW_Pin1_4 | 71 | 76 | PF00397 | 0.690 |
LIG_DLG_GKlike_1 | 129 | 137 | PF00625 | 0.475 |
LIG_FHA_1 | 121 | 127 | PF00498 | 0.534 |
LIG_FHA_1 | 47 | 53 | PF00498 | 0.573 |
LIG_FHA_2 | 140 | 146 | PF00498 | 0.509 |
LIG_FHA_2 | 164 | 170 | PF00498 | 0.467 |
LIG_FHA_2 | 79 | 85 | PF00498 | 0.533 |
LIG_Rb_pABgroove_1 | 147 | 155 | PF01858 | 0.482 |
LIG_SH2_STAP1 | 153 | 157 | PF00017 | 0.469 |
LIG_SH2_STAT5 | 111 | 114 | PF00017 | 0.450 |
LIG_SH2_STAT5 | 36 | 39 | PF00017 | 0.639 |
LIG_TRAF2_1 | 142 | 145 | PF00917 | 0.498 |
LIG_WRC_WIRS_1 | 90 | 95 | PF05994 | 0.455 |
MOD_CDK_SPxK_1 | 71 | 77 | PF00069 | 0.649 |
MOD_CDK_SPxxK_3 | 71 | 78 | PF00069 | 0.688 |
MOD_CK1_1 | 106 | 112 | PF00069 | 0.436 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.595 |
MOD_CK2_1 | 139 | 145 | PF00069 | 0.561 |
MOD_CK2_1 | 163 | 169 | PF00069 | 0.437 |
MOD_CK2_1 | 78 | 84 | PF00069 | 0.582 |
MOD_CK2_1 | 89 | 95 | PF00069 | 0.370 |
MOD_GSK3_1 | 103 | 110 | PF00069 | 0.425 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.565 |
MOD_N-GLC_1 | 4 | 9 | PF02516 | 0.569 |
MOD_NEK2_1 | 89 | 94 | PF00069 | 0.447 |
MOD_OFUCOSY | 3 | 9 | PF10250 | 0.458 |
MOD_PIKK_1 | 120 | 126 | PF00454 | 0.426 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.396 |
MOD_PKA_2 | 16 | 22 | PF00069 | 0.627 |
MOD_PKA_2 | 44 | 50 | PF00069 | 0.585 |
MOD_Plk_2-3 | 163 | 169 | PF00069 | 0.461 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.448 |
MOD_ProDKin_1 | 71 | 77 | PF00069 | 0.693 |
MOD_SUMO_for_1 | 160 | 163 | PF00179 | 0.592 |
MOD_SUMO_rev_2 | 132 | 142 | PF00179 | 0.494 |
MOD_SUMO_rev_2 | 98 | 106 | PF00179 | 0.518 |
TRG_DiLeu_BaEn_1 | 95 | 100 | PF01217 | 0.392 |
TRG_ER_diArg_1 | 14 | 17 | PF00400 | 0.684 |
TRG_ER_diArg_1 | 37 | 39 | PF00400 | 0.584 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJJ7 | Leptomonas seymouri | 58% | 100% |
A0A0S4JFK3 | Bodo saltans | 37% | 100% |
A0A3Q8IQR8 | Leishmania donovani | 99% | 100% |
A4HP11 | Leishmania braziliensis | 68% | 99% |
E9ASS1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 80% | 100% |
Q4Q1S5 | Leishmania major | 88% | 100% |